Effects of BM-MSCs on ROS generation in DCS rats. by Chen Lu (135200)

Subjects:

Effect of Bcl-xL on proteins involved in the apoptotic pathway of MDCK cells. by Jiahao Zheng (807470)

Subjects:

Differences in growth, metabolism and migration of BY-02 cells compared with WT cells. by Jiahao Zheng (807470)

Subjects:

Pretreatment of BM-MSCs improves the survival rate and incidence of DCS. by Chen Lu (135200)

Subjects:

Analysis and comparison of transcriptome data between WT and BY-02 cells. by Jiahao Zheng (807470)

Subjects:

The targeting strategies, qRT-PCR, and western bolt to verify BY-02 cells. by Jiahao Zheng (807470)

Subjects:

Pretreatment of BM-MSCs attenuates DCS induced lung inflammation. by Chen Lu (135200)

Subjects:

Effect of Bcl-xl on the tumorigenicity of MDCK cells in nude mice. by Jiahao Zheng (807470)

Subjects:

The figure shows that <i>R</i>₀ decreases significantly under control strategies, particularly at temperatures near the peak transmission range, indicating the effectiveness of control mechanisms applied. by Lukas Degu Petros (22097332)

“…<p>The figure shows that <i>R</i>₀ decreases significantly under control strategies, particularly at temperatures near the peak transmission range, indicating the effectiveness of control mechanisms applied.…”

Effect of BM-MSCs in improving DCS induced lung injury. by Chen Lu (135200)

Subjects:

Transcriptome analysis. by Jiahao Zheng (807470)

Subjects:

Ranking of factors in order of importance as reported by survey respondents regarding the difficulty in accessing the lower uterine segment (A), complicated fetal extraction in ces... by María Jesús Cancelo Hidalgo (12154030)

Subjects:

Identification of BM-MSCs. by Chen Lu (135200)

Subjects:

Effects of BM-MSCs on different types of lung cell death in different group. by Chen Lu (135200)

Subjects:

The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of deaths in 2021; (b) The EAPC of d... by Juanjuan Li (399633)

Subjects:

Inpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

Outpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

Utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

The expenditure on anticoagulants in the period of 2019-2023(million CNY). by Wei Luo (80175)

Subjects:

Comparison of postoperative NLR, PLR, and SII between the two groups. by Changxu Wang (17826805)

Subjects: